Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 11 of 257 found articles
 
 
  166MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from BEGONIA, a phase Ib/II study
 
 
Title: 166MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from BEGONIA, a phase Ib/II study
Author: Schmid, P.
Jung, K.H.
Wysocki, P.J.
Jassem, J.
Ma, C.X.
Fernandes, R.
Huisden, R.
Stewart, R.
Vukovic, P.
Tablante Nunes, A.
Nowecki, Z.
Appeared in: Annals of oncology
Paging: Volume 33 () nr. S3 pages S199
Year: 2022
Contents:
Publisher: European Society for Medical Oncology
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 11 of 257 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands